Gufic BioSciences Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -
301.00 +2.30 (0.77%)Updated : 10 Apr 2026
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Total Operating Expense 702.47675.51575.29650.57
Other Net 0.45-0.53-0.46-0.90
Diluted Weighted Average Shares 10.039.859.699.69
Gain( Loss)on Saleof Assets 0.12-2.300.030.07
Depreciation/ Amortization 21.0617.0222.2817.13
Operating Income 117.33131.15115.33128.58
Net Income 69.6586.1479.7095.84
Income Availableto Com Excl Extra Ord 69.6586.1479.7095.84
Other Operating Expenses Total 5.445.414.6017.44
Net Income Before Taxes 94.14115.67106.72126.84
Minority Interest 0.00---
Net Income After Taxes 69.6586.1479.7095.84
Income Availableto Com Incl Extra Ord 69.6586.1479.7095.84
Costof Revenue Total 415.12427.38364.27441.60
Gross Profit 404.68379.29326.35337.56
Interest Inc( Exp) Net- Non- Op Total -23.75-12.65-8.18-0.91
Diluted Net Income 69.6586.1479.7095.84
DPS- Common Stock Primary Issue 0.100.100.10-
Provisionfor Income Taxes 24.4929.5427.0231.00
period Type ----
Net Income Before Extra Items 69.6586.1479.7095.84
Total Revenue 819.81806.67690.62779.16
period Length 12.0012.0012.0012.00
Revenue 819.81806.67690.62779.16
Selling/ General/ Admin Expenses Total 255.25220.30178.99169.97
Diluted Normalized EPS 6.948.928.229.88
Research Development 5.615.415.164.43
Diluted EPS Excluding Extra Ord Items 6.958.748.229.89
Unusual Expense( Income) ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,414.00+23.00(1.65%)
801.40-42.95 (-5.09%)
979.80-40.25 (-3.95%)